Mojo Fertility had built AI-based sperm-testing technology, but traditional lab testing was still slow, inaccessible and inaccurate for many consumers, and the company needed a way to make testing easier to adopt and easier to deliver safely outside the clinic.
Reported impact
Mojo made fertility testing more accessible, more marketable and easier to scale by combining AI-based analysis with a home-testing experience, faster logistics and a stronger route to consumers and clinics.
Mojo Fertility worked with EY teams to extend its AI-based sperm analysis technology into a direct-to-consumer service. Mojo's core technology counts sperm with high accuracy and computes sperm count, motility and DNA integrity, but the broader challenge was operationalizing that capability for consumers and clinics. EY researched target audiences, repositioned the value proposition around men's health data, and designed the Mojo Home Kit so users could collect samples at home and send them to the lab quickly. The solution combined the AI testing capability with a digitally coordinated pickup experience, packaging built to keep samples viable and a service flow that made the lab process simpler for end users. By pairing AI-based analysis with product design, logistics and a targeted launch campaign, Mojo turned a specialized diagnostic workflow into a more scalable customer experience.
Users collect a sample with the Mojo Home Kit and collection flask, then the digital platform triggers rapid pickup and transport to the lab. Once received, Mojo's AI-based testing computes sperm count, motility and DNA integrity so results can be returned through the service flow without the manual counting bottleneck of traditional testing.
"Since then, the valuation of the company has doubled."
"The EY team also deployed services, including visual identity, packaging design, digital product design, customer experience and copywriting."
"The EY team took the home-testing kit from concept to public launch in just six months."
"The Mojo Home Kit is a home testing kit where men can collect a sample and ship it directly to the lab for testing."
"The company created a new piece of AI-based technology that can count sperm with 95% accuracy and compute sperm count, sperm motility and the integrity of the sperm's DNA."
Review how this reference was scored and trace each normalized claim back to its documented source.
Scoring methodology
Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.
Traceability
Field coverage shows which facts each source supports. Dates are shown only when documented by the source.
The average number of persons, including directors, employed by the company during the year was as follows: 2024 Number Employees 1.
Related
EY Sample Archived · Jun 13, 2025 St James's Hospital St James's Hospital needed to modernize aging laboratory infrastructure because legacy on-premises systems slowed genomic diagnostics, limited storage for sequencing data, complicated ISO 15189 compliance and reduced… 24/7, 365-day access to the cloud-based genome sequencing tools Azure · Microsoft Fabric · cloud-based genome sequencing tools EY Sample Archived · Apr 15, 2024 Takeda After Takeda's integration with Shire, finance processes and data structures were heterogeneous, invoice handling was vulnerable to disruption, and the organization needed a way to democratize automation and AI skills… 190 ideas CFOInUrpocket · Power BI · UiPath EY Sample Feb 1, 2023 unknown A global biopharmaceutical company had already begun using AI but lacked a mature governance model, creating gaps in how projects were reviewed for bias, privacy, third-party risk and regulatory readiness at a time when… AI governance framework · central AI inventory · global Responsible AI framework 